Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer's disease is a research paper published in EBioMedicine (2025). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Alzheimer's Association
Grant: 23AARF-1027342
National Institute of Neurological Disorders and Stroke
Grant: NS1 07265
National Institute on Aging
Grant: U19 AG069701
National Institute on Aging
Grant: AG 062135
National Institute on Aging
Grant: AG 5549-06
National Institutes of Health
Grant: ADDF 291204
National Institutes of Health
Grant: UG3/UH3 NS 113776
NIA NIH HHS
Grant: RF1 AG055549
National Institutes of Health
Grant: 1U19AG069701-01
Biology and pathobiology of apoE in aging and Alzheimer's disease
National Institutes of Health
Grant: 4UH3NS113776-02
Small Molecule Mitochondria-Targeted Therapeutics for AD
Alzheimer's Drug Discovery Foundation
National Institutes of Health Blueprint for Neuroscience Research
FWCI
3.59
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords